We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$768M
AUM Growth
+$22.8M
(+3.1%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,093
New
800
Increased
114
Reduced
121
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.93M |
| 2 |
CACI
CACI
|
+$5.05M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.9M |
| 4 |
Yelp
YELP
|
+$4.72M |
| 5 |
Norfolk Southern
NSC
|
+$4.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradata
TDC
|
+$6.01M |
| 2 |
Gilead Sciences
GILD
|
+$5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.91M |
| 4 |
Copa Holdings
CPA
|
+$4.6M |
| 5 |
Lowe's Companies
LOW
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.19% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.55% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
501
DELISTED
Sprint Corporation
S
| $33K | ﹤0.01% |
+6,769
| New | +$36.1K |
|
502
Expedia Group
EXPE
$37.3B
| $32K | ﹤0.01% |
+293
| New | +$34.1K |
|
503
HSBC
HSBC
$356B
| $32K | ﹤0.01% |
+722
| New | +$34.4K |
|
504
Live Nation Entertainment
LYV
$42.1B
| $32K | ﹤0.01% |
759
-77,717
| -99% | -$3.45M |
|
505
Newell Brands
NWL
$2.56B
| $32K | ﹤0.01% |
+1,260
| New | +$35.6K |
|
|
MRO
506
DELISTED
Marathon Oil Corporation
MRO
| $32K | ﹤0.01% |
+1,967
| New | +$32.7K |
|
|
NTG
507
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
| $32K | ﹤0.01% |
+200
| New | +$36.8K |
|
|
ETFC
508
DELISTED
E*Trade Financial Corporation
ETFC
| $32K | ﹤0.01% |
+578
| New | +$30.8K |
|
509
Chemours
CC
$2.37B
| $31K | ﹤0.01% |
+637
| New | +$31.8K |
|
510
Coty
COTY
$2.48B
| $31K | ﹤0.01% |
+1,671
| New | +$32.8K |
|
511
Healthpeak Properties
DOC
$14.8B
| $31K | ﹤0.01% |
+1,348
| New | +$31.3K |
|
|
JWN
512
DELISTED
Nordstrom
JWN
| $31K | ﹤0.01% |
+650
| New | +$32.3K |
|
513
Masco
MAS
$15.3B
| $31K | ﹤0.01% |
+756
| New | +$32.5K |
|
514
Molina Healthcare
MOH
$10.3B
| $31K | ﹤0.01% |
384
-15,137
| -98% | -$1.22M |
|
515
Tortoise North American Pipeline ETF
TPYP
$852M
| $31K | ﹤0.01% |
+1,500
| New | +$33.7K |
|
|
UNVR
516
DELISTED
Univar Solutions Inc.
UNVR
| $31K | ﹤0.01% |
+1,123
| New | +$33K |
|
|
XL
517
DELISTED
XL Group Ltd.
XL
| $31K | ﹤0.01% |
+564
| New | +$24.8K |
|
|
TSS
518
DELISTED
Total System Services, Inc.
TSS
| $31K | ﹤0.01% |
+365
| New | +$31.4K |
|
519
PBF Energy
PBF
$7.31B
| $30K | ﹤0.01% |
875
-54,916
| -98% | -$1.77M |
|
520
Sonic Automotive
SAH
$2.61B
| $30K | ﹤0.01% |
+1,565
| New | +$31.6K |
|
|
TECD
521
DELISTED
Tech Data Corp
TECD
| $30K | ﹤0.01% |
355
-16,787
| -98% | -$1.63M |
|
522
Brighthouse Financial
BHF
$3.5B
| $29K | ﹤0.01% |
+556
| New | +$32.1K |
|
523
Eversource Energy
ES
$27.2B
| $29K | ﹤0.01% |
+494
| New | +$29.2K |
|
524
Annaly Capital Management
NLY
$17.4B
| $29K | ﹤0.01% |
+691
| New | +$29.4K |
|
525
Ventas
VTR
$47.9B
| $29K | ﹤0.01% |
+576
| New | +$30.2K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
BGIM
CIA
Convergence Investment Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.
- Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
- Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
- Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
- Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
- Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
- Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.
Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.